欢迎进入 投资云南@云南招商网

州市招商

文山

项目查询

关键字:
所属行业:
投资金额:
- 万元
 
您现在的位置是: 首页--生物医药和大健康--详细
虾青素精深加工项目Astaxanthin Intensive Processing Project
发布时间:2016-07-07 14:44:56   来源:本站   作者:   点击:367次

Name

虾青素精深加工项目

Astaxanthin Intensive Processing Project

Industry Involved

Modern Bio-medicine

Site

Kunming National Biological Industry Base (Core Area)

Description

Natural astaxanthin is a kind of super-strong antioxidant and has the efficacies of anti-aging and immunity enhancement. It has thus been extensively used in such fields as health care products, cosmetics, foods, and feed additives. This project aims at production of astaxanthin oiling agents and development of astaxanthin soft capsules and astaxanthin cosmetics by relying on intensive processing of astaxanthin raw materials of haematococcus pluvialis scaled breeding base of Yunnan Yuncai Jinke Bio-technology Co., Ltd.

Content

Construction scale: The total floor area is 21,150 m2. It includes the construction of astaxanthin oiling agent production workshop, astaxanthin soft capsule production workshop, astaxanthin cosmetic production workshop, raw material warehouse, finished goods warehouse, comprehensive office building, living service area and public utilities. After completion, the production scale will be 50t astaxanthin oiling agent (including 5% of astaxanthin), 500,000 bottles of astaxanthin soft capsules, and 500,000 bottles of astaxanthin cosmetics each year.

Construction duration: 2 years

Land area: 27.1 mu

Supporting Conditions

Kunming High-tech Zone is the first national level new & high-tech industrial development zone in Yunnan Province approved by the State Council in 1992. It consists of two blocks: main urban area located in northwest main urban area of Kunming City and new and high-tech industrial base located in Majinpu Street, new Chenggong District. Total planned area of new and high-tech industrial base in Kunming new urban district is 4365.65 hectares, including 3013.40 hectares for urban construction. It is designed as the functional structure of "one axis, two arteries, four centers, four zones and two blocks". In 2015, Kunming High-tech Zone realized a general financial revenue of RMB 4081 million and local public fiscal budget revenue of RMB 1805 million. Currently, there are 185 high-tech enterprises herein. Kunming National Biological Industry Base (Core Area) has gathered 80% biotech enterprises above designated size of the whole province, including 247 bio-industry enterprises with Bayer AG, Israel Baker Norton Pharmaceutical Co., Ltd., HongKong Jida Pharmaceutical Co., Ltd., China National Medicines Corporation Ltd., Yunnan Baiyao Group Co., Ltd. and KPC Pharmaceuticals, Inc. as leading enterprises (including marketing and distribution enterprises). Among them, 43 enterprises are rated as high-tech enterprises; 28 enterprises are enterprises above designated size; the number of enterprises with total operating revenue exceeding RMB 100 million is 23; there are more than 60 national, provincial and municipal enterprise technology and joint engineering research center, innovative enterprises and innovative pilot enterprises. In October 2013, Phase I of "haematococcus pluvialis scaled breeding base" in Taiwan Farmers Entrepreneurial Park in Shilin, Kunming City was completed and put into operation. This project is invested and built by Yunnan Yuncai Jinke Bio-technology Co., Ltd. Investment on Phase I is about RMB 100 million and the land area is 150 mu. International leading tubular photobioreactor culture technique and process are adopted for the whole project. Annual output of lyophilized haematococcus pluvialis powder is above 100t and more than 3t high-quality pure natural astaxanthin can be extracted. The output is expected to capture 30% share of global market. After Phase II is completed and put into operation, annual output of lyophilized haematococcus pluvialis powder will exceed 300t and 10t high-quality pure natural astaxanthin can be extracted. This base will become the largest haematococcus pluvialis breeding base in China.

Investment Estimate and Fund Raising

Investment estimate: A total investment of RMB 330,346,000, including RMB 130,346,000 of self-raised funds and RMB 200 million from financial institutions.

Fund raising: self raising by enterprise and bank loans

Preferential Policies Applicable

This project can enjoy the preferential policies in Collection of Policies for Kunming High-tech Industrial Development Zone in 2013 and related policies in Notice of Administrative Committee of Kunming Hi-tech Industrial Development Zone on Distribution of Implementation Opinions on Quickening the Construction of "Yunnan Medicine" Industrial Base and Fostering "Yunnan Medicine" Characteristic Industrial Cluster.

Market Prediction (Analysis)

Astaxanthin is a kind of fat-soluble carotenoid (also a kind of haematochrome) and natural astaxanthin is a kind of super-strong antioxidant. Its antioxidant capacity is 6000 times that of ordinary vitamin C and 10 times that of natural beta carotene. Tests show that astaxanthin has such physiological effects as tumor inhibition, immunity enhancement and removal of internal free radicals. It also shows sound therapeutic efficacy in skin cancer caused by ultraviolet ray and good preventive and therapeutic efficacy in eye disease caused by diabetes. According to financial statements of several U.S. companies manufacturing astaxanthin health care products, annual growth rate of astaxanthin exceeds 29% and astaxanthin has promising market in such fields as foods, cosmetics and medicines. Currently, only the market value of astaxanthin used in aquaculture is about USD 1 billion. Current annual demand on astaxanthin as a health care product in China is about 10t. With economic development of China, the potential demand on astaxanthin as health care product and medicine will be very high.

Profit Model and Preliminary Benefit Analysis

Economic benefit: After this project reaches the design capacity, the sales revenue of astaxanthin oiling agent, astaxanthin soft capsules and astaxanthin cosmetics may reach RMB 850 million, the corporate income tax may reach RMB 33,135,000, annual net profit may reach RMB 99,405,000 and the payback period is 5.3 years.

Social benefit: This project will promote the development of astaxanthin industry in Kunming City and increase job opportunities.

Risk Analysis

As a kind of good antioxidant product, astaxanthin has no high profile in China and consumer recognition needs to be elevated. Therefore, main risks are marketing risks. Furthermore, consumers are limited due to high price of antioxidant.

Cooperation Pattern

Joint venture, cooperation and sole proprietorship

Contact Information

Contact Unit: Investment Promotion Bureau of Kunming City

Contact Person: Zhou Jing

Tel.: 0871-68155141

Fax: 0871-68155141

E-mail: gxqswb@163.com


关于我们| 商会平台| 信息公开| 联系我们 滇ICP备08002862号

0871-67195654/67195610

电子邮件:yunnanzs@163.com

云南招商官方微信

法制在线官方微信

管理员登录      不良信息报警      云南网监      网站备案      平台入口      招商大数据平台项目查询系统